A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]